Clinical trials: Mammography
Breast Cancer Screening
Effect of Information About the Benefits and Harms of Mammography on Women's Decision Making
The aim of this study is to assess the effect of receiving information about the benefits and harms of mammography screening on informed choice, decisional conflict, intention to participate in the Early Detection of Breast…
- Trial name
- InforMa (NCT03046004)
- Testing
- Decision aid for breast cancer screening, Standard leaflet
- Where
- Spain
- Volunteers
- 400 people
- Sponsor
- Institut de Recerca Biomèdica de Lleida
Breast Cancer Screening
Evaluation of an mHealth Intervention to Promote Participation in Breast Cancer Screening in Argentina
We carried out with a mixed-method study including a pragmatic randomized controlled trial to evaluate effectiveness of the intervention and quantitative and qualitative evaluation of the implementation from women and…
- Trial name
- NCT06500936
- Testing
- SMS
- Where
- Argentina
- Volunteers
- 248 people, healthy volunteers welcome
- Sponsor
- Centro de Estudio de Estado y Sociedad
Triple Negative Breast Cancer
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
The aim of our study is to find the best imaging technique, alone or in combination, that can best predict a complete response (absence of tumour cells).
- Trial name
- PRECISION (NCT06879704)
- Testing
- Imaging assessment
- Where
- France
- Volunteers
- 115 people
- Sponsor
- Centre Henri Becquerel
Breast Neoplasms
Positron Emission Tomography in Patients With Breast Cancer
This is a prospective study evaluating the role of Positron Emission Tomography (PET scan) in breast cancer. The radiopharmaceutical [18F] 2-deoxyglucose will be used as both an imaging modality and to evaluate tumor metabolism…
- Trial name
- NCT00001385
- Where
- United States
- Volunteers
- 75 people
- Sponsor
- National Cancer Institute (NCI)
Breast Cancer
Study Into the Use of Electrical Impedance Mammography in the Diagnosis and Characterisation of Breast Disease
The Signascan Electrical Impedance Mammography (EIM) Study is a pilot study of a non-invasive medical device - a novel approach to breast cancer detection using Electrical Impedance Mammography (passing minute electrical currents…
- Trial name
- Signascan (NCT01217489)
- Testing
- Breast scan - Electrical Impedance Mammography
- Where
- United Kingdom
- Volunteers
- 300 people
- Sponsor
- Oxford University Hospitals NHS Trust
Breast Carcinoma
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge
This clinical trial studies contrast enhanced spectral mammography (CESM) for the evaluation of pathologic nipple discharge. CESM is similar to standard mammography, but it includes an intravenous (by vein) injection of an…
- Trial name
- NCT05056844
- Testing
- Contrast Enhanced Digital Mammography, Digital Tomosynthesis Mammography, Iodinated Contrast Agent
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- M.D. Anderson Cancer Center
Breast Cancer, Obesity, Morbid
Weight Loss and Breast Cancer
Obesity is an important risk factor for postmenopausal breast cancer. A large meta-analysis concluded that obesity is associated with a 20% to 40% increased risk for receptor-positive postmenopausal breast cancer.
- Trial name
- NCT05654571
- Testing
- mammography
- Where
- Turkey (Türkiye)
- Volunteers
- 300 people
- Sponsor
- Fatih Sultan Mehmet Training and Research Hospital
Breast Cancer
Collection of FUJIFILM's 3Dimensional Mammograms
This image-acquisition study is designed to acquire the study image data and establish and document the clinical findings for each subject.
- Trial name
- 3DM (NCT01542814)
- Testing
- 3Dimensional Mammography, 2D FFDM
- Where
- 3 sites in United States
- Volunteers
- 600 people, healthy volunteers welcome
- Sponsor
- Fujifilm Medical Systems USA, Inc.
Breast Cancer
Pilot Mammography Reader Study to Assess Breast Cancer Detection in FFDM Plus DBT Versus FFDM Alone
The purpose of this pilot is to provide credible performance estimate information in order to conduct subsequent reader studies.
- Trial name
- NCT02511730
- Testing
- FFDM Plus DBT, FFDM
- Where
- 4 sites in United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Fujifilm Medical Systems USA, Inc.
Mammogram Scheduled
Video-assisted Intervention for Increasing Mammography Uptake in Private Primary Care in Singapore
Breast cancer is the leading female cancer in Singapore, but 3 in 5 women are not going for their regular mammography screenings at recommended frequencies despite 15 years of nationwide efforts by Breast Screen Singapore.
- Trial name
- NCT02108314
- Testing
- Video Screening and Counselling
- Where
- Singapore
- Volunteers
- 448 people, healthy volunteers welcome
- Sponsor
- National University Health System, Singapore
This Study Evaluates Interventions to Increase Surveillance Mammography Uptake for Early Breast Cancer Detection Among Singaporean Women
Trial to Evaluate the Impact of Various Behavioural Interventions to Increase Mammography Uptake Among Singaporean Women
Breast cancer is the leading cancer among women in Singapore, yet mammography screening rates remain critically low at 34.7%, despite the availability of a national program since 2002.
- Trial name
- PROMPT (NCT07283107)
- Testing
- Arm 2: One mailed reminder, Arm 3: Two mailed reminders, Arm 4: Mailed reminder with prescheduled appointment
- Where
- Singapore
- Volunteers
- 8,910 people, healthy volunteers welcome
- Sponsor
- National University Hospital, Singapore